Clinical Trials Logo

Clinical Trial Summary

if amifampridine can improve neuromuscular transmission in muscles previously injected with OnabotulinumtoxinA (BTX-A)


Clinical Trial Description

Amifampridine may also be effective in treating the sequelae of botulinum toxin injections and this study will determine if neuromuscular transmission as measured by single fiber electromyography is improved in patients treated with BTX-A following administration of amifampridine ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05769478
Study type Interventional
Source Wake Forest University Health Sciences
Contact Katherinne S Velasquez
Phone 336.716.6031
Email kserrano@wakehealth.edu
Status Recruiting
Phase Phase 1
Start date September 15, 2023
Completion date June 2024

See also
  Status Clinical Trial Phase
Completed NCT03603665 - A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults Phase 1
Not yet recruiting NCT04550793 - Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients
Completed NCT01441557 - Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism Phase 2/Phase 3
Withdrawn NCT01940315 - Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B Phase 3
Enrolling by invitation NCT02051062 - BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients Phase 4
Completed NCT02055183 - BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin
Completed NCT01357213 - Phase 1 PK Study of XOMA 3AB Phase 1
Completed NCT03676634 - Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG® Phase 2
Completed NCT00314080 - Treatment of Survivors After Botulism Outbreak N/A
Not yet recruiting NCT06112834 - Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG® Phase 2
Completed NCT00348426 - Botulism Outbreak in Thailand (Episode II) Phase 4
Completed NCT00004401 - Study of Human Botulism Immunoglobulin in Infants With Botulism N/A
Completed NCT01701999 - Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid Phase 2
Completed NCT02779140 - Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 Phase 1